
Cognex (CGNX) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Mar 2025Income Metrics
Revenue
216.0M
Gross Profit
144.3M
66.81%
Operating Income
26.1M
12.08%
Net Income
23.6M
10.93%
EPS (Diluted)
$0.14
Balance Sheet Metrics
Total Assets
1.9B
Total Liabilities
486.9M
Shareholders Equity
1.4B
Debt to Equity
0.34
Cash Flow Metrics
Operating Cash Flow
47.4M
Free Cash Flow
38.0M
Revenue & Profitability Trend
Cognex Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 914.5M | 837.5M | 1.0B | 1.0B | 811.0M |
Cost of Goods Sold | 288.7M | 236.3M | 284.2M | 277.3M | 206.4M |
Gross Profit | 625.8M | 601.2M | 721.9M | 759.8M | 604.6M |
Gross Margin % | 68.4% | 71.8% | 71.8% | 73.3% | 74.5% |
Operating Expenses | |||||
Research & Development | 139.8M | 139.4M | 141.1M | 135.4M | 131.0M |
Selling, General & Administrative | 370.9M | 339.1M | 312.1M | 309.4M | 267.6M |
Other Operating Expenses | - | - | - | - | - |
Total Operating Expenses | 510.7M | 478.5M | 453.2M | 444.7M | 398.6M |
Operating Income | 115.1M | 122.7M | 268.7M | 315.1M | 206.0M |
Operating Margin % | 12.6% | 14.7% | 26.7% | 30.4% | 25.4% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | - | - | - | - | - |
Other Non-Operating Income | 16.4M | 12.6M | -18.0M | 3.8M | -19.1M |
Pre-tax Income | 131.5M | 135.3M | 250.7M | 318.9M | 186.9M |
Income Tax | 25.3M | 22.1M | 35.2M | 39.0M | 10.7M |
Effective Tax Rate % | 19.3% | 16.3% | 14.0% | 12.2% | 5.7% |
Net Income | 106.2M | 113.2M | 215.5M | 279.9M | 176.2M |
Net Margin % | 11.6% | 13.5% | 21.4% | 27.0% | 21.7% |
Key Metrics | |||||
EBITDA | 132.3M | 132.5M | 305.8M | 331.0M | 251.3M |
EPS (Basic) | $0.62 | $0.66 | $1.24 | $1.59 | $1.02 |
EPS (Diluted) | $0.62 | $0.65 | $1.23 | $1.56 | $1.00 |
Basic Shares Outstanding | 171438000 | 172249000 | 173407000 | 176463000 | 173489000 |
Diluted Shares Outstanding | 171438000 | 172249000 | 173407000 | 176463000 | 173489000 |
Income Statement Trend
Cognex Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 186.1M | 202.7M | 181.4M | 186.2M | 269.1M |
Short-term Investments | 60.0M | 129.4M | 218.8M | 137.5M | 103.2M |
Accounts Receivable | 143.4M | 114.2M | 125.4M | 130.3M | 125.7M |
Inventory | 157.5M | 162.3M | 122.5M | 113.1M | 60.8M |
Other Current Assets | 63.4M | 68.1M | 67.5M | 68.7M | 37.2M |
Total Current Assets | 613.4M | 679.0M | 717.7M | 639.8M | 601.7M |
Non-Current Assets | |||||
Property, Plant & Equipment | 112.8M | 36.2M | 27.2M | 53.7M | 52.4M |
Goodwill | 860.6M | 899.3M | 497.7M | 495.3M | 503.7M |
Intangible Assets | 90.7M | 113.0M | 12.4M | 11.9M | 15.6M |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 397.2M | 407.5M | 413.9M | 425.8M | 442.5M |
Total Non-Current Assets | 1.4B | 1.3B | 1.2B | 1.4B | 1.2B |
Total Assets | 2.0B | 2.0B | 2.0B | 2.0B | 1.8B |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 38.0M | 21.5M | 27.1M | 44.1M | 16.3M |
Short-term Debt | 8.9M | 9.6M | 8.5M | 7.8M | 8.1M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | 169.4M | 151.9M | 187.7M | 188.6M | 132.3M |
Non-Current Liabilities | |||||
Long-term Debt | 61.4M | 69.0M | 31.3M | 17.8M | 18.1M |
Deferred Tax Liabilities | 243.5M | 273.6M | 265.8M | 308.5M | 329.2M |
Other Non-Current Liabilities | 1.1M | 299.0K | 1.9M | 15.5M | 10.0M |
Total Non-Current Liabilities | 306.0M | 361.2M | 332.0M | 385.0M | 406.2M |
Total Liabilities | 475.3M | 513.1M | 519.7M | 573.6M | 538.5M |
Equity | |||||
Common Stock | 341.0K | 343.0K | 345.0K | 351.0K | 352.0K |
Retained Earnings | 499.3M | 512.5M | 528.2M | 562.9M | 487.9M |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.5B | 1.5B | 1.4B | 1.4B | 1.3B |
Key Metrics | |||||
Total Debt | 70.2M | 78.6M | 39.8M | 25.6M | 26.2M |
Working Capital | 444.0M | 527.1M | 530.0M | 451.2M | 469.4M |
Balance Sheet Composition
Cognex Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 106.2M | 113.2M | 215.5M | 279.9M | 176.2M |
Depreciation & Amortization | 32.7M | 21.9M | 19.6M | 20.3M | 26.5M |
Stock-Based Compensation | 52.4M | 54.8M | 54.5M | 43.8M | 42.7M |
Working Capital Changes | -20.0M | -18.1M | -68.1M | -12.1M | -23.0M |
Operating Cash Flow | 153.5M | 158.6M | 243.6M | 331.3M | 228.8M |
Investing Activities | |||||
Capital Expenditures | -15.0M | -23.1M | -19.7M | -15.5M | -13.3M |
Acquisitions | -1.4M | -257.1M | -5.0M | 0 | 1.0M |
Investment Purchases | -850.9M | -184.1M | -233.7M | -668.1M | -922.9M |
Investment Sales | 828.4M | 496.5M | 254.0M | 431.0M | 1.1B |
Investing Cash Flow | -39.0M | 32.3M | -4.5M | -252.5M | 169.4M |
Financing Activities | |||||
Share Repurchases | -67.1M | -79.8M | -204.3M | -161.7M | -51.0M |
Dividends Paid | -52.3M | -49.1M | -45.9M | -43.3M | -390.5M |
Debt Issuance | - | - | - | - | - |
Debt Repayment | - | - | - | - | - |
Financing Cash Flow | -119.4M | -128.9M | -250.2M | -204.9M | -442.6M |
Free Cash Flow | 134.0M | 89.8M | 223.7M | 298.6M | 229.1M |
Net Change in Cash | -4.9M | 62.0M | -11.1M | -126.2M | -44.4M |
Cash Flow Trend
Cognex Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
57.01
Forward P/E
42.76
Price to Book
4.58
Price to Sales
7.41
PEG Ratio
42.76
Profitability Ratios
Profit Margin
13.13%
Operating Margin
17.44%
Return on Equity
8.10%
Return on Assets
4.11%
Financial Health
Current Ratio
3.29
Debt to Equity
5.52
Beta
1.47
Per Share Data
EPS (TTM)
$0.72
Book Value per Share
$8.97
Revenue per Share
$5.47
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
cgnx | 6.9B | 57.01 | 4.58 | 8.10% | 13.13% | 5.52 |
Garmin | 43.8B | 28.06 | 5.39 | 20.73% | 23.21% | 2.34 |
Keysight | 27.8B | 38.05 | 5.07 | 14.30% | 14.53% | 50.48 |
MKS Instruments | 6.3B | 27.98 | 2.67 | 9.50% | 6.21% | 199.70 |
Vontier | 6.1B | 15.86 | 5.10 | 35.39% | 12.99% | 177.14 |
Itron | 5.6B | 21.06 | 3.49 | 18.76% | 11.05% | 77.85 |
Financial data is updated regularly. All figures are in the company's reporting currency.